晶品特装(688084) - 2025 Q3 - 季度财报
2025-10-29 09:40
Financial Performance - The company's operating revenue for the third quarter reached ¥135,483,074.38, representing a year-on-year increase of 321.47%[3] - The total profit for the third quarter was ¥17,664,499.47, with a significant increase attributed to higher operating revenue compared to the same period last year[8] - The net profit attributable to shareholders for the third quarter was ¥18,431,495.46, reflecting a substantial increase due to increased product deliveries[8] - The basic earnings per share for the third quarter was ¥0.24, up from ¥0.14 in the same period last year[3] - The net profit excluding non-recurring gains and losses for the third quarter was ¥16,412,165.13, a significant improvement compared to the previous year[3] - Total operating revenue for the first three quarters of 2025 reached ¥212.14 million, a significant increase from ¥68.20 million in the same period of 2024, representing a growth of 211.5%[18] - The net profit for the first three quarters of 2025 was ¥5.34 million, a turnaround from a net loss of ¥30.50 million in the same period of 2024[19] - The company reported a gross profit of ¥58.52 million for the first three quarters of 2025, compared to a gross loss of ¥-30.39 million in 2024[18] - The company achieved a basic earnings per share of ¥0.14 for the first three quarters of 2025, compared to a loss per share of ¥-0.37 in the same period of 2024[19] Research and Development - Research and development expenses totaled ¥9,962,572.81, accounting for 7.35% of operating revenue, a decrease from 28.94% year-on-year[4] - Research and development expenses for the first three quarters of 2025 were ¥34.91 million, slightly down from ¥36.10 million in 2024, reflecting a decrease of 3.3%[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,846,143,695.41, an increase of 4.62% compared to the previous year[4] - The total assets of the company as of the reporting date amounted to ¥1,846.14 million, an increase from ¥1,764.68 million in the previous year, showing a growth of 4.6%[17] - The total liabilities increased to ¥291.46 million in 2025 from ¥213.76 million in 2024, marking a rise of 36.3%[17] - The equity attributable to shareholders of the parent company was ¥1,568.15 million, slightly up from ¥1,562.54 million in the previous year, indicating a growth of 0.4%[17] Cash Flow - The net cash flow from operating activities was not applicable for the current period, but it was reported as -¥10,190,528.59 for the year-to-date[3] - In the first three quarters of 2025, the cash inflow from operating activities was CNY 229,786,586.62, a significant increase from CNY 126,428,384.54 in the same period of 2024, representing an increase of approximately 81.7%[21] - The net cash flow from operating activities was negative CNY 10,190,528.59, an improvement compared to negative CNY 64,194,546.24 in the first three quarters of 2024[21] - The cash inflow from investment activities totaled CNY 2,397,563,532.89, up from CNY 2,036,420,318.08 in the previous year, marking an increase of about 17.7%[22] - The net cash flow from investment activities was positive CNY 155,461,159.49, a turnaround from negative CNY 242,885,784.67 in the same period of 2024[22] - The cash inflow from financing activities was CNY 25,743,757.08, compared to CNY 20,809,297.27 in the previous year, reflecting an increase of approximately 23.3%[22] - The net cash flow from financing activities was positive CNY 2,176,348.27, improving from negative CNY 114,528,103.06 in the first three quarters of 2024[22] - The total cash and cash equivalents at the end of the period increased to CNY 824,865,828.63 from CNY 805,062,438.96 at the end of the same period last year[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,677[11] - The largest shareholder, Tianjin Junrong Huizhi Technology Center (Limited Partnership), holds 25.08% of shares, totaling 18,973,030 shares[11] - The company has three major shareholders, all controlled by the same individual, Chen Bo[12] - The total number of shares held by the company's repurchase account is 1,559,671, representing 2.0614% of the total share capital[12] Other Information - The company expects continued growth in product deliveries and revenue in the upcoming quarters, driven by market expansion strategies[8] - The company announced a delay in the completion of the smart equipment Beijing industrial base project from September 2025 to October 2026[14] - The company's cash and cash equivalents as of September 30, 2025, amount to ¥827,331,479.03, an increase from ¥680,612,648.23 at the end of 2024[15] - Accounts receivable increased to ¥242,023,759.75 from ¥144,518,505.79 in the previous year, indicating a growth of approximately 67.5%[15] - Inventory as of September 30, 2025, is valued at ¥189,215,204.34, up from ¥153,323,606.28, reflecting a growth of about 23.4%[15] - The trading financial assets decreased to ¥175,000,000.00 from ¥385,264,234.03, a decline of approximately 54.5%[15] - The company received CNY 199,253,958.96 in cash from sales of goods and services, a substantial increase from CNY 60,009,214.30 in the first three quarters of 2024, indicating a growth of approximately 232.5%[21] - The company reported cash received from tax refunds of CNY 9,971,991.35, significantly higher than CNY 112,359.57 in the same period of 2024[21] - The company has not adopted new accounting standards or interpretations that would affect the financial statements for the year of first execution[23]
羚锐制药(600285) - 2025 Q3 - 季度财报
2025-10-29 09:40
Financial Performance - The company's operating revenue for the third quarter reached ¥942,156,123.36, representing a year-on-year increase of 10.44%[4] - The total profit for the quarter was ¥206,011,250.06, reflecting a growth of 10.75% compared to the same period last year[4] - The net profit attributable to shareholders was ¥176,546,803.24, which is a 9.77% increase year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥162,725,925.99, up by 10.41% from the previous year[4] - The basic earnings per share for the quarter was ¥0.312, an increase of 9.09% compared to the same period last year[5] - Total operating revenue for the first three quarters of 2025 reached ¥3,041,361,639.17, an increase of 10.2% compared to ¥2,759,116,202.14 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was ¥653,536,523.20, compared to ¥573,907,880.00 in 2024, representing a growth of 13.9%[21] - Basic earnings per share for the first three quarters of 2025 increased to ¥1.148, up from ¥1.024 in the same period of 2024[22] Assets and Liabilities - The total assets of the company at the end of the reporting period amounted to ¥5,755,687,724.88, marking a 14.73% increase from the end of the previous year[5] - Total assets as of the end of the reporting period amounted to ¥5,755,687,724.88, compared to ¥5,016,843,207.73 at the end of 2024, marking an increase of 14.7%[18] - Total liabilities increased to ¥2,472,402,407.84 from ¥1,936,551,143.73, reflecting a rise of 27.6%[18] - The total liabilities were not explicitly stated but are essential for assessing the company's financial health[15] Cash Flow - The cash flow from operating activities for the year-to-date was ¥490,387,656.36, showing a significant increase of 40.09%[5] - The company's cash flow from operating activities for the first three quarters of 2025 showed a positive trend, indicating improved liquidity[23] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately CNY 3.11 billion, an increase of 17% compared to CNY 2.66 billion in the same period of 2024[25] - Net cash flow from operating activities was CNY 490.39 million in the first three quarters of 2025, up from CNY 350.05 million in 2024, representing a growth of 40%[25] - The ending cash and cash equivalents balance for the first three quarters of 2025 was CNY 459.66 million, down from CNY 772.44 million in 2024[26] Equity - The equity attributable to shareholders increased to ¥3,248,239,730.07, which is a 5.72% rise compared to the previous year[5] - The total equity attributable to shareholders increased to ¥3,248,239,730.07 from ¥3,072,526,287.29, reflecting a growth of 5.7%[18] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥104,600,773.85, up from ¥74,489,927.63 in 2024, indicating a focus on innovation[21] Other Information - The company has not reported any significant changes in shareholder structure or major transactions during the reporting period[14] - There are no new product launches or technological advancements mentioned in the conference call[14] - Future outlook and performance guidance were not detailed in the provided documents[14] - The company reported a goodwill of CNY 482,016,236.04, indicating significant intangible asset value[16] - The company will not apply new accounting standards starting from 2025[27]
山东黄金(600547) - 2025 Q3 - 季度财报

2025-10-29 09:35
山东黄金矿业股份有限公司 2025 年第三季度报告 证券代码:600547 证券简称:山东黄金 山东黄金矿业股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 27,017,278,703.76 | 27.25 | 83,78 ...
太和水(605081) - 2025 Q3 - 季度财报
2025-10-29 09:35
Financial Performance - The company's operating revenue for the third quarter was ¥48,335,771.76, representing a year-on-year increase of 143.45%[2] - The total profit for the period was -¥25,256,136.68, with a net profit attributable to shareholders of the listed company at -¥25,381,073.77[2] - The basic earnings per share for the quarter was -¥0.22, compared to -¥0.73 for the year-to-date[2] - Total operating revenue for the first three quarters of 2025 was CNY 81,386,642.64, a decrease of 14.5% compared to CNY 94,999,836.48 in the same period of 2024[18] - Net loss for the first three quarters of 2025 was CNY 83,729,512.69, compared to a net loss of CNY 35,973,023.75 in the same period of 2024, representing a significant increase in losses[19] - The company's operating profit (loss) for the period was CNY -79,385,117.76, worsening from CNY -31,101,021.11 in the previous year[19] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY -0.73, compared to CNY -0.32 in the same period of 2024[20] Cash Flow and Liquidity - The net cash flow from operating activities was ¥9,792,670.01, a significant improvement compared to -¥29,548,913.80 for the year-to-date[2] - The company's cash flow from operating activities showed a significant decline, impacting liquidity and operational flexibility[21] - Cash inflow from operating activities for the first three quarters of 2025 was $293.78 million, an increase of 53.6% compared to $191.16 million in the same period of 2024[22] - Net cash outflow from operating activities was $29.55 million for the first three quarters of 2025, improving from a net outflow of $96.75 million in the same period of 2024[22] - The ending cash and cash equivalents balance for the first three quarters of 2025 was $90.67 million, down from $190.21 million in the same period of 2024[23] - Total cash outflow from operating activities was $323.32 million in 2025, compared to $287.90 million in 2024, reflecting an increase of 12.3%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,310,288,116.69, down 14.12% from the end of the previous year[3] - Total assets decreased from CNY 1,525,768,444.25 to CNY 1,310,288,116.69, reflecting a decline of approximately 14.1%[16] - Total liabilities decreased from CNY 553,326,160.45 to CNY 417,316,306.76, a reduction of about 24.6%[16] - Total current assets as of September 30, 2025, amount to 102,784,428.63 RMB, down from 188,229,802.82 RMB as of December 31, 2024[14] - Accounts receivable decreased to 386,317,311.21 RMB from 585,085,036.52 RMB year-over-year[14] - Inventory increased to 122,315,843.99 RMB from 104,224,698.45 RMB year-over-year[14] - Contract assets rose to 139,783,952.79 RMB from 127,825,409.74 RMB year-over-year[14] Shareholder Information - Total number of common shareholders at the end of the reporting period is 7,254[10] - The largest shareholder, Beijing Xinxin Xuancan Technology Center, holds 13,589,649 shares, representing 12.00% of total shares[10] - The second-largest shareholder, He Wenhui, holds 11,963,918 shares, representing 10.56% of total shares, with 5,169,094 shares frozen and 6,794,824 shares marked[12] Operational Challenges - The company faced increased operating costs and management expenses, affecting overall profitability[7] - The weighted average return on net assets was -2.81% for the quarter, reflecting ongoing financial challenges[3] - Non-recurring gains and losses for the period totaled -¥2,972,703.24, with significant impacts from asset disposals and government subsidies[6] - The company has been placed under delisting risk warning due to financial performance issues, with specific criteria outlined for potential delisting[13] - The company reported a significant decrease in cash and cash equivalents, indicating potential liquidity concerns[14] - Research and development expenses for the first three quarters of 2025 were CNY 5,017,456.96, down from CNY 6,283,086.93 in the previous year, indicating a reduction in investment in innovation[18] - The company reported an increase in credit impairment losses of CNY -22,736,441.63, compared to a gain of CNY 6,278,920.48 in the same period of 2024, highlighting challenges in asset quality[19] Market Activity - The company reported an increase in construction project numbers, contributing to revenue growth in the engineering sector[7] - The company did not report any significant new product launches or market expansions during the conference call[24]
电科数字(600850) - 2025 Q3 - 季度财报
2025-10-29 09:35
Financial Performance - The company's operating revenue for the third quarter reached ¥2,708,488,107.19, representing a year-on-year increase of 4.71%[4] - The total profit for the quarter was ¥147,583,345.66, showing a decrease of 20.19% compared to the same period last year[4] - The net profit attributable to shareholders was ¥147,207,322.70, down 12.78% year-on-year[4] - The basic earnings per share for the quarter was ¥0.2145, reflecting a decrease of 12.38% compared to the previous year[4] - Total operating revenue for the first three quarters of 2025 reached ¥7,563,243,563.34, an increase of 6.5% compared to ¥7,100,051,857.58 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was ¥247,934,519.08, a decrease of 18.8% from ¥305,598,754.27 in the previous year[20] - Basic earnings per share for the first three quarters of 2025 were ¥0.3714, down from ¥0.4383 in the same period of 2024[21] - The net profit for the first three quarters of 2025 was CNY 236,659,514.42, a decrease from CNY 292,987,780.78 in the same period of 2024, representing a decline of approximately 19.2%[32] - Operating profit for the first three quarters of 2025 was CNY 227,606,491.37, down from CNY 292,148,832.07 in 2024, indicating a decrease of about 22.1%[32] Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥-1,099,443,668.97 for the year-to-date[4] - Cash generated from operating activities amounted to ¥7,055,857,643.81, compared to ¥6,678,326,284.21 in the previous year, indicating a growth of 5.7%[23] - Operating cash inflow totaled ¥7,142,280,661.21, an increase from ¥6,758,493,813.55[24] - Cash flow from operating activities for the first three quarters of 2025 was negative at CNY -73,100,643.90, an improvement compared to CNY -119,394,566.09 in 2024[35] - The net cash flow from financing activities was ¥59,014,784.12, a significant recovery from -¥330,775,732.31 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥11,145,988,415.47, a decrease of 6.64% from the end of the previous year[5] - Total current assets as of September 30, 2025, amount to ¥9,987,671,659.11, a decrease from ¥10,817,647,592.63 at the end of 2024[16] - Total liabilities decreased to ¥6,226,257,885.64 from ¥6,989,602,409.51, a reduction of 10.9%[18] - Total liabilities decreased to ¥1,358,398,151.90 from ¥1,575,226,763.48, indicating improved financial stability[29] - The total assets as of September 30, 2025, were ¥4,673,926,929.10, down from ¥4,879,968,940.57, indicating a contraction in asset base[29] Shareholder Information - Total equity attributable to shareholders was ¥4,861,893,808.27, showing a slight increase of 0.49% compared to the previous year[5] - Total equity attributable to shareholders increased slightly to ¥4,861,893,808.27 from ¥4,838,060,231.21, showing a growth of 0.5%[18] - Total number of common shareholders at the end of the reporting period is 38,721[12] - The largest shareholder, East China Computer Technology Research Institute, holds 139,598,271 shares, representing 20.52% of total shares[12] Operational Efficiency - Total operating costs increased to ¥7,335,877,191.80, up from ¥6,786,098,303.79, reflecting a rise of 8.1%[19] - Gross profit margin decreased as cost of goods sold rose to ¥905,870,903.76 from ¥506,170,312.43, indicating increased operational costs[31] - The company reported a decrease in inventory to ¥488,755,363.10 from ¥542,423,331.83, suggesting improved inventory management[27] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥350,518,019.68, an increase from ¥329,134,175.75 in 2024, reflecting a growth of 6.5%[19] - Research and development expenses increased to ¥34,036,529.53 from ¥27,210,003.37, reflecting a focus on innovation[31] Other Financial Metrics - The weighted average return on equity was 3.04%, a decrease of 0.70 percentage points from the previous year[5] - The company reported a decrease in interest income to ¥10,066,301.22 from ¥21,357,120.66, a decline of 53.9%[20] - Other comprehensive income after tax for the first three quarters of 2025 was -¥3,755,096.09, compared to -¥7,697,786.53 in the previous year, indicating an improvement[21] - The company incurred credit impairment losses of CNY -2,717,320.29 in 2025, compared to CNY -1,196,575.60 in 2024, indicating a significant increase in losses[32] Government Support - The company received government subsidies amounting to ¥32,892,063.33, which are related to its normal business operations[9] Strategic Developments - There are no significant new strategies or product developments mentioned in the conference call[14] - The company has not adopted new accounting standards or interpretations for the year 2025[37]
春秋电子(603890) - 2025 Q3 - 季度财报
2025-10-29 09:35
苏州春秋电子科技股份有限公司 2025 年第三季度报告 证券代码:603890 证券简称:春秋电子 债券代码:113577 债券简称:春秋转债 债券代码:113667 债券简称:春23转债 苏州春秋电子科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 1 / 14 苏州春秋电子科技股份有限公司 2025 年第三季度报告 单位:元 币种:人民币 | 非经常性损益项目 | 本期金额 | 年初至报告期末金额 说明 | | --- | --- | --- | | 非流动性资产处置损益,包括已计提资产减值准备的冲销部分 | -1,444,472.21 | -421,221.72 | | ...
凌云光(688400) - 2025 Q3 - 季度财报
2025-10-29 09:35
Financial Performance - The company's operating revenue for the third quarter reached ¥759,267,252.46, representing a year-on-year increase of 53.12%[4] - The total profit for the third quarter was ¥23,591,759.45, reflecting a growth of 56.16% compared to the same period last year[4] - The net profit attributable to shareholders was ¥36,585,014.05, an increase of 47.97% year-on-year[4] - The net profit excluding non-recurring gains and losses surged by 177.03% to ¥31,094,549.35 in the third quarter[4] - Basic and diluted earnings per share for the third quarter were both ¥0.08, marking a 60.00% increase compared to the previous year[5] - Total operating revenue for the first three quarters of 2025 reached ¥2,127,400,313.66, a 34.4% increase from ¥1,584,067,239.11 in the same period of 2024[21] - Operating profit for the first three quarters of 2025 was ¥115,192,369.02, compared to ¥82,846,856.31 in 2024, reflecting a growth of 39.0%[22] - Net profit attributable to shareholders of the parent company for the first three quarters of 2025 was ¥132,660,476.08, up from ¥111,987,354.93 in 2024, marking a 18.5% increase[22] - The comprehensive income total for the first three quarters of 2025 was ¥133,478,616.98, compared to ¥108,362,814.11 in 2024, reflecting a growth of 23.2%[22] - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.29, compared to ¥0.24 in 2024, an increase of 20.8%[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,004,785,930.19, up 10.01% from the end of the previous year[5] - The total liabilities increased to ¥1,980,434,888.53 in 2025 from ¥1,560,544,682.99 in 2024, representing a growth of 27.0%[21] - The total equity attributable to shareholders of the parent company rose to ¥4,037,623,785.70 in 2025, compared to ¥3,908,013,008.67 in 2024, an increase of 3.3%[21] - Current liabilities totaled CNY 539,628,424.77 as of September 30, 2025, compared to CNY 551,046,191.60 at the end of 2024, indicating a reduction in short-term obligations[30] - The company's total equity increased marginally to CNY 3,742,323,968.61 as of September 30, 2025, from CNY 3,742,140,007.07 at the end of 2024, reflecting stable shareholder value[30] Cash Flow - The company's cash and cash equivalents amounted to ¥770,894,761.56 as of September 30, 2025, down from ¥2,065,942,144.70 at the end of 2024[15] - Cash inflow from operating activities for the first three quarters of 2025 was CNY 1,765,966,891.71, an increase from CNY 1,727,006,350.50 in the same period of 2024[25] - Net cash flow from operating activities was negative CNY 165,279,309.26 in 2025, compared to negative CNY 121,196,664.15 in 2024, indicating a decline in operational efficiency[25] - Total cash inflow from investment activities increased significantly to CNY 1,564,631,390.08 in 2025 from CNY 1,015,371,382.90 in 2024, reflecting a strong investment recovery[26] - Net cash flow from investment activities was negative CNY 241,367,458.32 in 2025, worsening from negative CNY 119,119,161.99 in 2024, suggesting increased capital expenditures[26] - Cash inflow from financing activities rose to CNY 611,855,000.00 in 2025, compared to CNY 302,960,622.89 in 2024, indicating improved financing conditions[26] - The net cash flow from financing activities was positive CNY 18,989,284.18 in 2025, a decrease from CNY 68,397,677.91 in 2024, showing reduced reliance on external financing[26] Research and Development - Research and development expenses totaled ¥120,127,573.61, accounting for 15.82% of operating revenue, a decrease of 4.42 percentage points year-on-year[5] - Research and development expenses for the first three quarters of 2025 were ¥318,871,386.39, up from ¥291,953,176.74 in 2024, indicating a 9.2% increase[21] - Research and development expenses increased to CNY 165.19 million, a rise of 1.0% from CNY 163.50 million in the previous year[32] Shareholder Information - The total number of ordinary shares at the end of the reporting period was 28,008,000[12] - The largest shareholder, Yao Yi, holds 200,237,818 shares, representing 43.44% of total shares[12] - The company held 6,061,847 shares in its repurchase account, accounting for 1.32% of total shares[13] - The company has no significant changes in the participation of major shareholders in margin trading or stock lending[14] Market Focus - The company is focusing on AI and intelligent manufacturing applications, which are expected to drive future growth and market expansion[10] - The company has made significant progress in product layout and market expansion, particularly in AI-driven communication and computing products[10]
亚辉龙(688575) - 2025 Q3 - 季度财报
2025-10-29 09:35
深圳市亚辉龙生物科技股份有限公司 2025 年第三季度报告 (一) 主要会计数据和财务指标 证券代码:688575 证券简称:亚辉龙 深圳市亚辉龙生物科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 单位:元 币种:人民币 项目 本报告期 本报告期比 上年同期增 减变动幅度 (%) 年初至报告期末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 478,273,760.85 10.25 1,286,711,447.77 -7.69 利润总额 41,549,908.17 -10.52 64,477,689.50 -70.72 归属于上市公司股东的 ...
同庆楼(605108) - 2025 Q3 - 季度财报
2025-10-29 09:35
Financial Performance - In Q3 2025, the company reported revenue of CNY 565.59 million, a decrease of 4.77% year-on-year[5]. - The total profit for Q3 2025 was a loss of CNY 41.28 million, representing a decline of 1,208.13% compared to the same period last year[3]. - The net profit attributable to shareholders was a loss of CNY 41.80 million, down 63.79% year-on-year[3]. - For the first nine months of 2025, the company reported revenue of CNY 1.90 billion, a growth of 1.66% year-on-year, driven by new store openings[6]. - The net profit attributable to shareholders for the first nine months was CNY 30.20 million, a decrease of 63.79% compared to the previous year[6]. - The net profit attributable to shareholders for the year-to-date period decreased by 63.79%[11]. - The net profit for the first three quarters of 2025 is CNY 30,197,564.03, a decrease of 63.8% compared to CNY 83,396,171.69 in the same period of 2024[22]. - The total comprehensive income for the first three quarters of 2025 is CNY 30,197,564.03, down from CNY 83,396,171.69 in 2024, indicating a decline of 63.8%[22]. - Basic and diluted earnings per share for the first three quarters of 2025 are both CNY 0.12, compared to CNY 0.32 in 2024, reflecting a decrease of 62.5%[22]. Cash Flow and Management - The company achieved a net cash inflow from operating activities of CNY 178 million in Q3 2025, an increase of 9.66% year-on-year[5]. - The cash inflow from operating activities for the first nine months was CNY 506 million, an increase of 37.41% year-on-year, indicating strong cash management[7]. - Net cash flow from operating activities for the year-to-date period increased by 37.41%[12]. - Cash flow from operating activities for the first three quarters of 2025 is CNY 505,755,932.14, an increase of 37.5% compared to CNY 368,066,288.54 in 2024[25]. - The cash and cash equivalents at the end of the period increased to CNY 193,940,219.19 from CNY 55,610,137.16 in 2024[26]. Expansion and Operations - The company opened three new hotels and two new restaurants in the first nine months, contributing to its expansion strategy[7]. - The company faced significant losses from new store operations, amounting to approximately CNY 60 million due to high initial costs and increased depreciation[7]. - The company anticipates improved performance in Q4 2025 as new stores mature and the banquet peak season approaches[7]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,077[14]. - The largest shareholder, Hainan Puqing Investment Development Co., Ltd., holds 97,640,187 shares, accounting for 37.55% of total shares[14]. - The second-largest shareholder, Shen Jishui, holds 53,803,307 shares, accounting for 20.69% of total shares[14]. Assets and Liabilities - The company's total assets amounted to ¥5,940,945,180.74 as of September 30, 2025, compared to ¥5,365,280,567.78 at the end of 2024, reflecting a growth of approximately 10.7%[19]. - Total current assets increased to ¥705,863,765.21 as of September 30, 2025, compared to ¥643,771,412.05 at the end of 2024, reflecting a growth of about 9.7%[17]. - Total non-current assets reached ¥5,235,081,415.53 as of September 30, 2025, compared to ¥4,721,509,155.73 at the end of 2024, indicating an increase of approximately 10.9%[18]. - Total liabilities as of September 30, 2025, were ¥3,707,125,688.11, up from ¥3,130,578,637.62 at the end of 2024, representing an increase of about 18.4%[19]. Costs and Expenses - Total operating revenue for the first three quarters of 2025 reached ¥1,896,206,750.02, an increase from ¥1,865,172,389.52 in the same period of 2024, reflecting a growth of approximately 1.7%[21]. - Total operating costs for the first three quarters of 2025 were ¥1,843,157,467.62, compared to ¥1,764,804,046.55 in 2024, indicating an increase of about 4.4%[21]. - The gross profit margin for the first three quarters of 2025 was approximately 2.8%, down from the previous year's margin[21]. - Research and development expenses increased significantly to ¥2,049,793.06 in 2025 from ¥652,339.22 in 2024, marking a rise of over 213%[21]. Non-Recurring Losses - The company reported a significant increase in non-recurring losses, totaling -9,050.79[10]. - The company has identified certain items as non-recurring losses that are significant in amount[10]. Accounting Standards - The company has not applied new accounting standards or interpretations for the first time in 2025[27].
卓锦股份(688701) - 2025 Q3 - 季度财报
2025-10-29 09:35
Financial Performance - The company's operating revenue for the third quarter was ¥30,248,481.98, a decrease of 55.73% compared to the same period last year[4] - The total profit for the quarter was -¥35,259,689.67, reflecting a decline of 67.43% year-over-year[4] - The net profit attributable to shareholders was -¥33,242,063.88, down 76.46% from the previous year[4] - Total operating revenue for the first three quarters of 2025 was CNY 71,601,681.76, a decrease of 61.6% compared to CNY 186,323,714.81 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was a loss of CNY 52,255,204.68, compared to a loss of CNY 42,405,932.65 in the same period of 2024, indicating a worsening of 23.5%[22] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY -0.39, compared to CNY -0.32 in 2024, indicating a decline in earnings[22] Research and Development - Research and development expenses amounted to ¥7,896,004.35, an increase of 28.15% compared to the same quarter last year, representing 26.10% of operating revenue[5] - Research and development expenses increased to CNY 20,937,637.99 in 2025, up from CNY 17,283,404.00 in 2024, representing a growth of 21.5%[20] Cash Flow and Liquidity - The company reported a significant cash flow from operating activities of -¥11,050,692.11, a decrease of 216.96% compared to the previous quarter[4] - The company's cash and cash equivalents as of September 30, 2025, amount to ¥46,949,323.03, an increase from ¥29,659,576.08 as of December 31, 2024[15] - The net cash flow from operating activities was 565,818.72, a significant improvement compared to a net outflow of 10,508,532.97 in the previous period[24] - Cash inflows from financing activities increased to 385,269,980.00, compared to 207,959,217.00 in the prior period[24] - The net increase in cash and cash equivalents was 19,152,474.73, a recovery from a decrease of 58,437,963.79 in the prior period[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥484,694,715.33, a decrease of 17.36% from the end of the previous year[5] - Total assets as of September 30, 2025, are ¥484,694,715.33, down from ¥586,482,900.09 at the end of 2024[16] - The total liabilities decreased to CNY 337,572,096.67 in 2025 from CNY 387,595,076.75 in 2024, a reduction of 12.9%[18] - The total equity attributable to shareholders decreased to CNY 146,727,363.54 in 2025 from CNY 198,887,823.34 in 2024, a decline of 26.2%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 3,996[12] - The largest shareholder, Zhuo Weilong, holds 46,719,617 shares, representing 34.79% of the total shares[12] Business Strategy and Operations - The company is adjusting its business strategy to focus on cash flow recovery efficiency rather than scale expansion, leading to a significant reduction in new orders for traditional businesses[9] - The company is actively taking measures to resolve accounts receivable collection issues, including renegotiating repayment plans and legal actions[10] - The company has not reported any new strategies or significant market expansions during the reporting period[15] Audit and Compliance - The company has not received any audit opinions indicating issues with the financial statements for the reporting period[15]